Delivery Order SPE2DB20D1100-SPE2DB26FE0UH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,271.71 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg tablets in quantities of 100. This firm fixed-price contract, with an ultimate completion date of August 20, 2025, represents a competitively awarded, non-set-aside procurement executed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the...
- The Defense Logistics Agency awarded a delivery order valued at $1,907.65 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg tablets (100-count units). The award, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, utilizes firm fixed-price pricing with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $1,513.10, for the supply of Dextroamphetamine-Amphetamine 20 mg tablets (100 count). This is a firm fixed price, non-competitive delivery order with an ultimate completion date of October 31, 2025, issued on October 30, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 15 mg tablets (100 count) valued at $1,016.28 under a firm fixed price arrangement. The award, issued on October 27, 2025, with an ultimate completion date of October 28, 2025, represents a non-competitive delivery order issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a $2,819.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg tablets (100-count units). This is a non-set-aside contract with an ultimate completion date of September 24, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,037.28 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100 units. The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, utilizes firm fixed price pricing and carries no set-aside designation, indicating competitive award. Performance of this delivery order will occur at the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,430.14 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 5 mg tablets in quantities of 100, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed price contract represents a non-set-aside procurement and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a Delivery Order valued at $1,080.55 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100 on September 17, 2025, with completion scheduled for September 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a $1,377.89 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets (100-count units), with a completion date of August 18, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and is being performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 20 mg tablets (100 count) on October 28, 2025, with a ceiling value of $1,029.76 and an ultimate completion date of October 29, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB26FE0UHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,485.09 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg tablets (100-count units). This non-set-aside, competitively awarded contract employs firm fixed pricing and was executed on October 17, 2025, with an ultimate completion date of October 20, 2025. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company holds substantial contract volume with DLA and the Defense Health Agency, supplying a broad portfolio of pharmaceutical products ranging from specialized medications to generic drugs and medical supplies across multiple therapeutic domains. This delivery order for controlled-substance pharmaceuticals is consistent with AmerisourceBergen's established role as a primary vendor for federal medical supply chain requirements and reflects the company's capability to meet competitive federal procurement standards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 10/17/25 |